Table 2.
Minimum inhibitory concentrations of various antibiotics for Salmonella enterica serotype Paratyphi A isolated from travelers returning from Myanmar, Japan, from July 2014 to August 2015
| Antibiotic | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 |
|---|---|---|---|---|---|---|
| Ampicillin | ≤ 4, S | ≤ 4, S | ≤ 4, S | ≤ 4, S | ≤ 4, S | ≤ 4, S |
| Ampicillin/sulbactam | ≤ 4, S | ≤ 4, S | ≤ 4, S | ≤ 4, S | ≤ 4, S | ≤ 4, S |
| Piperacillin/tazobactam | ≤ 8, S | ≤ 8, S | ≤ 8, S | ≤ 8, S | ≤ 8, S | ≤ 8, S |
| Ceftriaxone | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S |
| Ceftazidime | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S |
| Cefepime | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S |
| Aztreonam | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S | ≤ 2, S |
| Meropenem | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S |
| Nalidixic acid | ≥ 64 | ≥ 64 | ≥ 64 | ≥ 64 | ≥ 64 | ≥ 64 |
| Levofloxacin | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S | ≤ 1, S |
| Levofloxacin (E-test) | 1.0, I | 2.0, R | 2.0, R | 1.0, I | 1.0, I | 1.0, I |
| Ciprofloxacin (E-test) | 0.5, I | 1.0, R | 1.0, R | 1.0, R | 0.5, I | 0.5, I |
I = intermediate; R = resistant; S = susceptible.